Czechia, March 18 -- Czechia based GlaxoSmithKline s.r.o. has secured contract from Ustredni vojenska nemocnice - Vojenska fakultni nemocnice Praha for Antivirals for systemic use Dolutegravir. The value of the contract is worth 1406922240 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....